Vitreoretinal Surgery Devices Market Size & Share 2025 – 2034

Vitreoretinal Surgery Devices Market Size

The global vitreoretinal surgery devices market size was valued at USD 1.7 billion in 2024 and is expected to exhibit growth at a CAGR of 3.4% from 2025 to 2034 period. The increasing prevalence of retinal diseases, rising demand for minimally invasive procedures, and the growth in outpatient surgeries are key factors propelling market progression.
 

Government and private sector initiatives aimed at improving awareness and treatment accessibility are expected to further accelerate industry expansion. Government-supported programs designed to raise awareness about retinal disorders and the importance of early intervention are driving demand for advanced surgical tools. Additionally, enhanced healthcare coverage and reimbursement for retinal surgeries in developed economies are reducing financial barriers, encouraging more patients to pursue treatment.
 

Minimally invasive techniques offer benefits such as reduced recovery times, lower risks of complications, and improved patient comfort, which in turn leads to higher acceptance rates. As a result, devices like microincision vitrectomy systems (MIVS) have become increasingly popular for their ability to minimize trauma and improve surgical outcomes. The development of advanced illumination devices is enhancing visibility, making complex procedures more manageable. Furthermore, newer formulations of silicone oils, gases, and surgical dyes are enhancing the effectiveness of retinal surgeries, driving product innovation.
 

Vitreoretinal surgery devices are specialized tools, instruments, and systems used in the diagnosis and surgical treatment of disorders affecting the vitreous humor (the gel-like substance filling the eye) and the retina.
 

Vitreoretinal Surgery Devices Market Trends

Technological innovations in vitreoretinal surgery devices have greatly transformed the field of ophthalmic surgery, providing solutions that are more precise, efficient, and patient-friendly.
 

• Real-time imaging during surgery allows surgeons to visualize retinal structures with unmatched clarity, enhancing surgical outcomes. The integration of imaging and surgical systems with digital platforms improves the planning and execution of complex procedures with greater accuracy.
   
• Fiberoptic probes with adjustable light intensity ensure optimal illumination of the surgical field, enhancing visibility even in the peripheral regions of the retina. Additionally, LED and xenon-based illumination systems provide consistent, high-quality lighting while minimizing heat generation, which helps reduce the risk of retinal damage.
   
• Moreover, newer formulations of gases (such as perfluoropropane and sulfur hexafluoride) and silicone oils are improving surgical efficacy and reducing complications.
   

Vitreoretinal Surgery Devices Market Analysis

Based on product, the market is segmented as vitreoretinal packs, photocoagulation lasers, vitrectomy machines, vitrectomy probes, illumination devices, and other products. The vitreoretinal packs segment accounted for majority revenue share and was valued at USD 602.1 million in 2024.
 

• Vitreoretinal packs contain pre-assembled, sterilized instruments and consumables, eliminating the need for separate procurement and sterilization. This convenience saves time for healthcare providers and enhances operational efficiency. By bundling essential components, these packs reduce overall procurement and preparation costs for healthcare facilities.
   
• Furthermore, manufacturers offer customizable options to meet specific surgical needs, making these packs more attractive to surgeons. Many vitreoretinal packs also feature single-use, disposable instruments, reducing the risk of cross-contamination and post-operative infections, which is a priority in modern surgical practices.
   

Based on surgery type, the vitreoretinal surgery devices market is segmented into posterior vitreoretinal surgery and anterior vitreoretinal surgery. The posterior vitreoretinal surgery segment is expected to drive business growth and expand at a CAGR of 3.5%, reaching around USD 1.9 billion by 2034.
 

• The availability of high-speed vitrectomy machines, intraoperative imaging, and small-gauge instruments significantly contribute to the segment's expansion. Modern machines that operate at higher cut rates make posterior segment surgeries safer and more efficient, encouraging their adoption.
   
• Moreover, older adults are more susceptible to conditions like macular holes, epiretinal membranes, and vitreomacular traction, which often require posterior segment surgery. Additionally, the increasing life expectancy worldwide is contributing to a larger pool of elderly patients in need of surgical interventions for posterior segment diseases.
   

Based on application, the vitreoretinal surgery devices market is segmented into diabetic retinopathy, retinal detachment, macular degeneration, and other applications. The diabetic retinopathy segment held leading share and was valued at USD 638.7 million in 2024.
 

• The rise in diabetes cases, particularly in developing regions such as Asia-Pacific, Latin America, and Africa, has led to an increasing number of diabetic retinopathy cases requiring surgical treatment.
   
• Additionally, minimally invasive vitreoretinal surgery techniques, like small-gauge vitrectomy systems, make surgeries more efficient and patient-friendly, encouraging their use in treating diabetic retinopathy.
   
• Moreover, awareness campaigns and improved healthcare access are promoting the early diagnosis of diabetic retinopathy, leading to more timely surgical interventions.
   

Based on end use, the vitreoretinal surgery devices market is classified into hospitals, ophthalmic clinics, ambulatory surgery centers, and other end users. The hospitals segment dominated the market with a revenue share of 47.9% in 2024.
 

• Hospitals house advanced equipment such as vitrectomy machines, photocoagulation lasers, and imaging systems, making them preferred venues for vitreoretinal surgeries. Tools like OCT-guided surgery and real-time imaging systems are predominantly available in hospitals, ensuring better outcomes and attracting patients.
   
• Additionally, the demand for vitreoretinal surgeries in hospitals remains significant due to their role as primary centers for advanced ophthalmic care. Hospitals, especially tertiary and multi-specialty institutions, are equipped with the infrastructure, skilled personnel, and technology to perform complex vitreoretinal procedures.
   

U.S. vitreoretinal surgery devices market accounted for USD 659.5 million in 2024 and is anticipated to grow at a CAGR of 2.7% between 2025 to 2034 period.
 

• Advances in intraoperative imaging systems, such as optical coherence tomography (OCT) and real-time retinal imaging, enable surgeons to achieve greater precision, further driving the demand for vitreoretinal surgery devices in healthcare settings.
   
• Increased awareness of retinal disorders and improvements in diagnostic imaging are leading to earlier detection, resulting in more patients opting for surgical interventions to preserve or restore vision, thus driving demand for vitreoretinal devices.
   
• Additionally, insurance coverage, especially through programs like Medicare, is making these high-cost procedures more accessible to the elderly population.
   

The UK vitreoretinal surgery devices market is projected to grow remarkably in the coming years.
 

• The rising prevalence of diabetes in the UK is a major factor contributing to the increase in retinal diseases such as diabetic retinopathy. This condition often requires vitreoretinal surgery to prevent or treat vision loss. Additionally, trauma or age-related changes can lead to retinal detachment, necessitating surgical interventions such as vitrectomy and retinal reattachment.
   
• There is also a growing trend toward robotic-assisted vitreoretinal surgery in the UK. These systems enhance the precision and efficiency of surgeries, leading to better clinical outcomes and increased patient demand for treatments.
   

China holds a dominant position in the Asia Pacific vitreoretinal surgery devices market.
 

• As China’s population ages, the incidence of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, is also increasing. The elderly population is projected to grow significantly, further driving the demand for surgical interventions related to retinal diseases.
   
• Additionally, China's private healthcare sector has seen considerable growth, with more individuals opting for private treatment to avoid long waiting times in public hospitals. The increasing number of private clinics offering advanced ophthalmic services, including vitreoretinal surgery, is contributing to the rising demand for these devices.
   

Vitreoretinal Surgery Devices Market Share

Key players in the market are focusing on innovation, expanding product portfolios, and enhancing the precision of surgical tools. Leading companies are investing in minimally invasive devices, such as small-gauge vitrectomy systems, to reduce recovery times and improve patient outcomes. They are also integrating advanced imaging technologies like OCT for better diagnostic capabilities and surgical precision.
 

Additionally, companies are exploring robotic-assisted surgeries to offer enhanced control and accuracy. Partnerships with hospitals and ophthalmic clinics, along with expanding their presence in emerging markets, are among the key strategies for development.
 

Vitreoretinal Surgery Devices Market Companies

Prominent players operating in the vitreoretinal surgery devices industry include:

• Alcon
• Bausch + Lomb
• BVI
• Carl Zeiss Meditec
• CooperVision
• Designs for Vision
• HOYA Surgical Optics
• MedOne
• OCULUS
• Oertli
• Peregrine Surgical
• STAAR SURGICAL
   

Vitreoretinal Surgery Devices Industry News:

• In June 2024, Alcon announced that its UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have received FDA clearance and will now be available in the U.S. This development will expand its product range and improve industry presence in the country.
   
• In December 2023, Carl Zeiss Meditec AG announced that it has entered into an agreement to acquire 100% shares of the Dutch Ophthalmic Research Center (International) B.V. (D.O.R.C.) from France based investment firm, Eurazeo SE. This strategic development will allow Zeiss to expand its portfolio significantly and further consolidate its industry presence.
   

The vitreoretinal surgery devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Market, By Product

• Vitreoretinal packs
• Photocoagulation lasers
• Vitrectomy machines
• Vitrectomy probes
• Illumination devices
• Other products

Market, By Surgery Type

• Posterior vitreoretinal surgery
• Anterior vitreoretinal surgery

Market, By Application

• Diabetic retinopathy
• Retinal detachment
• Macular degeneration
• Other applications

Market, By End Use

• Hospitals
• Ophthalmic clinics 
• Ambulatory surgery centers 
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE